104 related articles for article (PubMed ID: 3933824)
21. Expression of plasminogen activators and plasminogen activator inhibitor 1 in dedifferentiated chondrosarcoma.
Häckel C; Czerniak B; Ayala AG; Radig K; Roessner A
Cancer; 1997 Jan; 79(1):53-8. PubMed ID: 8988726
[TBL] [Abstract][Full Text] [Related]
22. Effects of castration on plasminogen activator activities and plasminogen activator inhibitor type 1 in the rat ventral prostate.
Wilson MJ; Ludowese C; Sinha AA; Estensen RD
Prostate; 1996 Apr; 28(4):239-50. PubMed ID: 8602400
[TBL] [Abstract][Full Text] [Related]
23. Expression of plasminogen activators and their inhibitors in human pancreatic carcinoma: immunohistochemical study.
Takeuchi Y; Nakao A; Harada A; Nonami T; Fukatsu T; Takagi H
Am J Gastroenterol; 1993 Nov; 88(11):1928-33. PubMed ID: 8237943
[TBL] [Abstract][Full Text] [Related]
24. Immunocytochemical localization of plasminogen activators in carcinomas in the cervix and vulva.
Parolini S; Rosa D; Flagiello D; Bonardi F; Rampinelli F; Bianchi UA; Molinari Tosatti MP
Int J Tissue React; 1994; 16(5-6):251-8. PubMed ID: 7558669
[TBL] [Abstract][Full Text] [Related]
25. Plasminogen activator profiles in neoplastic tissues of the human colon.
de Bruin PA; Griffioen G; Verspaget HW; Verheijen JH; Dooijewaard G; van den Ingh HF; Lamers CB
Cancer Res; 1988 Aug; 48(16):4520-4. PubMed ID: 3260815
[TBL] [Abstract][Full Text] [Related]
26. Expression of urokinase-type plasminogen activator (u-PA), u-PA receptor, and tissue-type PA messenger RNAs in human hepatocellular carcinoma.
De Petro G; Tavian D; Copeta A; Portolani N; Giulini SM; Barlati S
Cancer Res; 1998 May; 58(10):2234-9. PubMed ID: 9605771
[TBL] [Abstract][Full Text] [Related]
27. Secretion of proteinases from malignant and nonmalignant human breast tissue.
Recklies AD; Tiltman KJ; Stoker TA; Poole AR
Cancer Res; 1980 Mar; 40(3):550-6. PubMed ID: 6258782
[TBL] [Abstract][Full Text] [Related]
28. Urokinase system expression in gastric carcinoma: prognostic impact in an independent patient series and first evidence of predictive value in preoperative biopsy and intestinal metaplasia specimens.
Beyer BC; Heiss MM; Simon EH; Gruetzner KU; Babic R; Jauch KW; Schildberg FW; Allgayer H
Cancer; 2006 Mar; 106(5):1026-35. PubMed ID: 16435385
[TBL] [Abstract][Full Text] [Related]
29. Measurement of plasminogen activator system components in plasma and tumor tissue extracts obtained from patients with breast cancer: an EORTC Receptor and Biomarker Group collaboration.
Grebenchtchikov N; Maguire TM; Riisbro R; Geurts-Moespot A; O'Donovan N; Schmitt M; McGreal G; McDermott E; O'Higgins N; Brünner N; Sweep CG; Duffy MJ
Oncol Rep; 2005 Jul; 14(1):235-9. PubMed ID: 15944795
[TBL] [Abstract][Full Text] [Related]
30. Possible role of the plasminogen activation system in human subfertility.
Ebisch IM; Steegers-Theunissen RP; Sweep FC; Zielhuis GA; Geurts-Moespot A; Thomas CM
Fertil Steril; 2007 Mar; 87(3):619-26. PubMed ID: 17123524
[TBL] [Abstract][Full Text] [Related]
31. Collagenase secretion by human breast neoplasms: a clinicopathologic investigation.
Ogilvie DJ; Hailey JA; Juacaba SF; Lee EC; Tarin D
J Natl Cancer Inst; 1985 Jan; 74(1):19-27. PubMed ID: 2982053
[TBL] [Abstract][Full Text] [Related]
32. Identification of t-PA as the major active plasminogen activator in human milk.
Marshall JM; Rees MC; Cederholm-Williams SA
Thromb Haemost; 1986 Apr; 55(2):279-81. PubMed ID: 3087004
[TBL] [Abstract][Full Text] [Related]
33. Human urokinase receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography: comparison with urokinase levels.
Del Vecchio S; Stoppelli MP; Carriero MV; Fonti R; Massa O; Li PY; Botti G; Cerra M; D'Aiuto G; Esposito G
Cancer Res; 1993 Jul; 53(13):3198-206. PubMed ID: 7686450
[TBL] [Abstract][Full Text] [Related]
34. Plasminogen activator system in oral squamous cell carcinoma.
Baker EA; Leaper DJ; Hayter JP; Dickenson AJ
Br J Oral Maxillofac Surg; 2007 Dec; 45(8):623-7. PubMed ID: 17590247
[TBL] [Abstract][Full Text] [Related]
35. Simultaneous determination of free tissue-type and free urokinase-type plasminogen activators in biological fluids by a solid-phase immunoassay.
Kuo BS; Bjornsson TD
Anal Biochem; 1993 Feb; 209(1):70-8. PubMed ID: 8465964
[TBL] [Abstract][Full Text] [Related]
36. The effect of dietary supplementation with limonene or myo-inositol on the induction of neoplasia and matrix metalloproteinase and plasminogen activator activities in accessory sex organs of male Lobund-Wistar rats.
Wilson MJ; Lindgren BR; Sinha AA
Exp Mol Pathol; 2008 Oct; 85(2):83-9. PubMed ID: 18675799
[TBL] [Abstract][Full Text] [Related]
37. Messenger RNA for urokinase plasminogen activator is expressed in myofibroblasts adjacent to cancer cells in human breast cancer.
Nielsen BS; Sehested M; Timshel S; Pyke C; Danø K
Lab Invest; 1996 Jan; 74(1):168-77. PubMed ID: 8569179
[TBL] [Abstract][Full Text] [Related]
38. Retinoic acid enhances fibrinolytic activity in-vivo by enhancing tissue type plasminogen activator (t-PA) activity and inhibits venous thrombosis.
van Giezen JJ; Boon GI; Jansen JW; Bouma BN
Thromb Haemost; 1993 Apr; 69(4):381-6. PubMed ID: 8497851
[TBL] [Abstract][Full Text] [Related]
39. [Determination of plasminogen activator of the head and neck tumor tissue].
Ji X; Nong H; Huang G
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1994; 29(5):299-301. PubMed ID: 7718296
[TBL] [Abstract][Full Text] [Related]
40. Plasminogen activator in human tears.
Stevens JD; Marshall JM; Benjamin L; Cederholm-Williams SA; Bron AJ
Eye (Lond); 1992; 6 ( Pt 6)():653-8. PubMed ID: 1289146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
